Inverness Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Inverness Counsel's GILD Position: Q4 2021 in Review
Inverness Counsel sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 3,035 shares — an estimated $212K sold.
Inverness Counsel first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $48.5M in Q4 2013. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- Inverness Counsel reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
- Inverness Counsel sold 3,035 Gilead Sciences shares in Q4 2021, an estimated $212K.
- Inverness Counsel first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
- Inverness Counsel's Gilead Sciences position peaked at $48.5M in Q4 2013.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on Inverness Counsel's 13F filing for Q4 2021, filed 7 Feb 2022.